In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
Vanda Pharmaceuticals Inc (NASDAQ: VNDA) closed the day trading at $4.51 up 0.22% from the previous closing price of $4.50. In other words, the price has increased by $0.22 from its previous closing price. On the day, 0.73 million shares were traded. VNDA stock price reached its highest trading level at $4.52 during the session, while it also had its lowest trading level at $4.41.
Ratios:
For a better understanding of VNDA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.37 and its Current Ratio is at 4.39. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on October 31, 2024, initiated with a Buy rating and assigned the stock a target price of $18.
On July 11, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $11.
Jefferies Downgraded its Buy to Hold on February 25, 2022, whereas the target price for the stock was revised from $24 to $12.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 06 ’25 when Polymeropoulos Mihael Hristos bought 10,000 shares for $5.01 per share. The transaction valued at 50,150 led to the insider holds 2,295,731 shares of the business.
Polymeropoulos Mihael Hristos bought 10,000 shares of VNDA for $50,200 on Mar 05 ’25. The President and CEO now owns 2,285,731 shares after completing the transaction at $5.02 per share. On Mar 03 ’25, another insider, Polymeropoulos Mihael Hristos, who serves as the President and CEO of the company, bought 10,000 shares for $4.71 each. As a result, the insider paid 47,050 and bolstered with 2,275,731 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VNDA now has a Market Capitalization of 263005168 and an Enterprise Value of -99860800. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.32 while its Price-to-Book (P/B) ratio in mrq is 0.49. Its current Enterprise Value per Revenue stands at -0.502 whereas that against EBITDA is 3.07.
Stock Price History:
The Beta on a monthly basis for VNDA is 0.69, which has changed by -0.08333331 over the last 52 weeks, in comparison to a change of 0.101756096 over the same period for the S&P500. Over the past 52 weeks, VNDA has reached a high of $6.75, while it has fallen to a 52-week low of $3.87. The 50-Day Moving Average of the stock is -3.41%, while the 200-Day Moving Average is calculated to be -9.77%.
Shares Statistics:
Over the past 3-months, VNDA traded about 647.06K shares per day on average, while over the past 10 days, VNDA traded about 647570 shares per day. A total of 58.31M shares are outstanding, with a floating share count of 54.39M. Insiders hold about 6.73% of the company’s shares, while institutions hold 75.03% stake in the company. Shares short for VNDA as of 1741910400 were 3560629 with a Short Ratio of 5.50, compared to 1739491200 on 3723179. Therefore, it implies a Short% of Shares Outstanding of 3560629 and a Short% of Float of 7.380000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
